← Leaderboards
Stephanie Teal
University Of Colorado
$1,491,989
Attributed
$1,491,989
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $381.1K · FY2014–25$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,491,989 · 2
By mechanism
N01$1,491,989 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanNational Institute Of Child Health And Human DevelopmentContraceptive MethodsContraceptive AgentsClinical Trials NetworkFemale Contraceptive AgentsProtocols DocumentationSafetyObesityClinical TrialsSiteContractsMissionProtocol DevelopmentDevicesPharmaceutical PreparationsEnrollmentUnited States Food And Drug AdministrationVenous ThromboembolismDrug CandidateGynecologicFormulationTreatment TrialFemale
Grant awards (20)
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM â CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - CU DENVER$3,381
N01 · FY2025 · HD · contact PI
CCTN-PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION - CU DENVER$111,644
N01 · FY2024 · HD · contact PI
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM â CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - CU DENVER$16,815
N01 · FY2024 · HD · contact PI
CCTN-PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONOGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$65,873
N01 · FY2023 · HD · contact PI
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES$1,660
N01 · FY2023 · HD · contact PI
CCTN-PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONOGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$115,176
N01 · FY2021 · HD · contact PI
CCTN - CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION: EFFICACY STUDY$17,274
N01 · FY2021 · HD · contact PI
CCTN - CLINICAL EVALUATION OF LONG ACTING REVERSIBLE CONTRACEPTIVES$117,736
N01 · FY2020 · HD · contact PI
CCTN - CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION: EFFICACY STUDY$25,912
N01 · FY2020 · HD · contact PI
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES$11,847
N01 · FY2020 · HD · contact PI
CCTN - CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION: EFFICACY STUDY$119,481
N01 · FY2019 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$8,636
N01 · FY2019 · HD · contact PI
CCTN-PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONOGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$214,033
N01 · FY2018 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$8,636
N01 · FY2018 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$8,636
N01 · FY2017 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$8,636
N01 · FY2016 · HD · contact PI
CCTN - CLINICAL EVALUATION OF LONG ACTING REVERSIBLE CONTRACEPTIVES$237,836
N01 · FY2015 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$17,678
N01 · FY2015 · HD · contact PI
CCTN - CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION: EFFICACY STUDY$362,333
N01 · FY2014 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$18,766
N01 · FY2014 · HD · contact PI